Added to YB: 2025-11-21
Pitch date: 2025-11-19
LFMD [neutral]
LifeMD, Inc.
-39.85%
current return
Author Info
Company Info
LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States.
Market Cap
$147.0M
Pitch Price
$4.09
Price Target
N/A
Dividend
N/A
EV/EBITDA
-7.32
P/E
-5.51
EV/Sales
0.67
Sector
Health Care Technology
Category
growth
Earnings and Other Updates: $LFMD
LFMD (update): Telehealth co +34% revenue growth, +294% adj EBITDA in 9M 2025 vs 2024. Partnered w/ Medifast's trainer network for GLP-1 distribution edge vs competitors relying on costly customer acquisition. Strategic branded GLP-1 focus (Lilly/Novo) vs risky compounded drugs. Debt-free after WorkSimpli divestiture at 0.78x P/S ratio.
Read full article (2 min)